JTO Impact Factor

2021 JTO Impact Factor Released

The Journal of Thoracic Oncology's 2021 has risen to 20.121, up from 15.609 last year. JTO ranks 4/65 respiratory medicine journals, and 13/245 oncology journals! As the leading thoracic oncology journal, its strength is in its multidisciplinary approach to research.
Skyline of Vienna Austria

WCLC 2022 Abstract Titles Released

Abstract titles have been released & registration is open for the 2022 World Conference on Lung Cancer. The program will feature 300+ oral & mini-oral presentations featuring the latest research in lung and thoracic cancers. Explore the full WCLC 2022 Program & Register Today!
Landmarks of Nara Japan, including Todaiji Temple

Abstract Submission for ACLC 2022 Now Open

The Scientific Program Committee for the IASLC 2022 Asia Conference on Lung Cancer is inviting the submission of scientific abstracts. The deadline for submission is Friday, June 24, 2022 at 23:59 PST.
2021 JTO Impact Factor Released
WCLC 2022 Abstract Titles Released
Abstract Submission for ACLC 2022 Now Open

Homepage

The International Association for the Study of Lung Cancer

The IASLC is a global multidisciplinary organization dedicated to eradication of all forms of lung cancer. From provision of educational events around the world and virtually to research projects and publications that advance the science of lung cancer, the IASLC's members—consisting of medical, surgical, and radiation oncologists, as well as other thoracic oncology specialists such as nurses, basic scientists, pathologists, radiologists, pulmonologists, statisticians, patient research advocates, patients, and their caregivers—are raising the bar for care of patients with lung cancer.

Explore More

In Focus

Air Pollution and Lung Cancer - The IASLC Position Statement

Lung cancer is a complicated disease with many causes. Among them are tobacco smoke, radon, and asbestos. However, one largely overlooked cause is the relationship between air pollution and lung cancer.

THE IASLC ATLAS OF DIAGNOSTIC IMMUNOHISTOCHEMISTRY (IHC)

New Translations of the IASLC IHC Atlas are available! From IHC biochemistry basics to identifying biomarkers, this text provides a comprehensive view of diagnostic IHC in a reader-friendly format.

Language Guide page 1

IASLC Language Guide

In line with the IASLC Equity Statement and in step with the ASCO Language of Respect, we are proud to announce the release of the IASLC Language Guide. The guide was established to instill best practices with commonly used phrases related to patient care. The IASLC will be folding the language found in the guide into all aspects of thoracic oncology education, from abstracts to faculty guidelines to podium presentations. 

Our Impact

8,000+ members from over 100 countries, all united by a single goal: to conquer thoracic cancers worldwide.

Our Impact

8,000+ members from over 100 countries, all united by a single goal: to conquer thoracic cancers worldwide.

See More

Our Work

The IASLC Staging Project

The IASLC Staging Project is a global effort to study and improve the current staging system for lung cancer, mesothelioma, thymic and esophageal cancer.

Lung Ambition Alliance

The IASLC has formed an alliance with three other founding organizations to allow scientists, specialists, advocates, and patients to break the barriers limiting progress and double 5-year survival rates of lung cancer by 2025.

In Numbers

8,000+ members from over 100 countries, all united by a single goal: to conquer thoracic cancers worldwide.
45
Years Experience
15K
Number of Research Awards Funded
20.121
JTO Impact Factor
8K+
Members

Upcoming Meetings & Webinars

IASLC Meeting
Aug 05 - Aug 05 2022
JTO-CRR_Hero-0820 - Cropped.jpg

Journal of Thoracic Oncology & JTO Clinical and Research Reports

Lung and thoracic specialists count on the IASLC’s journals to provide perspective on innovation in prevention, detention, diagnosis and cutting-edge treatments. As a leading medical journal, JTO focuses on lung and thoracic cancers and is dedicated to presenting original research reviews and opinions from a wide range of disciplines within the medical community. JTO CRR, the official open access journal of the IASLC, complements the JTO by offering authors a gold open access publication option.